{"id":"W3137324665","doi":"10.1097/mnh.0000000000000703","title":"Sodium/glucose cotransporter 2 inhibitors in chronic kidney disease and heart failure: ready for prime time in patients without diabetes","year":2021,"lang":"en","type":"review","venue":"Current Opinion in Nephrology & Hypertension","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Empagliflozin; Dapagliflozin; Kidney disease; Diabetes mellitus; Canagliflozin; Internal medicine; Renal function; Heart failure; Hazard ratio; Clinical endpoint; Randomized controlled trial; Glycemic; Type 2 diabetes; Urology; Endocrinology; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001504535,0.000751365,0.005851841,0.001310351,0.000213871,0.001715287,0.0009204675,0.001536135,0.00477923],"category_scores_gemma":[0.006425359,0.0003644914,0.00368646,0.001888267,0.0002469683,0.0009368521,0.0004983845,0.001403897,0.0005826145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005875318,"about_ca_system_score_gemma":0.001866728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001859979,"about_ca_topic_score_gemma":0.003948539,"domain_scores_codex":[0.9990451,0.0003033831,0.0003108428,0.000111302,0.0001765121,0.00005284244],"domain_scores_gemma":[0.996437,0.002338328,0.0008392547,0.00003152518,0.0002540516,0.00009993593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001672704,0.00006798899,0.0006576582,0.6083276,0.005547396,0.00009552992,0.00009222812,0.0001502968,0.0002508075,0.0004667591,0.01824141,0.3644296],"study_design_scores_gemma":[0.003428536,0.001589085,0.01229383,0.6359707,0.058574,0.001183665,0.0003054944,0.0003100613,0.0004431451,0.001097314,0.284719,0.00008512791],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001866755,0.9992525,0.00001955825,0.0001629239,0.0001657821,0.00001694754,0.00004616547,0.000002776373,0.0001466615],"genre_scores_gemma":[0.002823497,0.9961081,0.00008586119,0.0005219852,0.0002431332,0.00004238933,0.00005784868,0.000002363608,0.0001147815],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005851841,"threshold_uncertainty_score":0.01598811,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03913448343923256,"score_gpt":0.314318908370095,"score_spread":0.2751844249308625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}